Mandate

Vinge advises Active Biotech on directed new share issue

April 06, 2010

The biotechnology company, Active Biotech (NASDAQ OMX Stockholm) is carrying out a directed new issue of shares for approximately SEK 149 million to funds managed by Sectoral Asset Management Inc. Vinge is acting for Active Biotech.

Vinge’s team consists of Erik Sjöman and Christian Lindhé.

Related

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026

Vinge represents Studsvik AB (publ) in the acquisition of Kärnfull Next AB

Vinge has represented Studsvik AB (publ) in connection with the acquisition of Kärnfull Next AB, a company developing methods for building small modular nuclear reactors.
March 10, 2026